We are looking for 2–17 years of age to join a clinical research study to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or Crohn’s and UC (including associated symptoms such as painful joints, fever, bloody stool, weight loss and/or liver disease), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your 2–17 years of age may be eligible to take part.
Your child may be eligible to take part in the IBD research studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
See if your child is eligible.
